Targeting the tumour stroma to improve cancer therapy

[1]  Z. Herceg,et al.  DNA methylation signal has a major role in the response of human breast cancer cells to the microenvironment , 2017, Oncogenesis.

[2]  Joel s. Brown,et al.  Classifying the evolutionary and ecological features of neoplasms , 2017, Nature Reviews Cancer.

[3]  P. Kantoff,et al.  Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing , 2017, JAMA.

[4]  G. Parmigiani,et al.  Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer , 2017, Nature Communications.

[5]  X. Bian,et al.  High‐mobility group box 1 released by autophagic cancer‐associated fibroblasts maintains the stemness of luminal breast cancer cells , 2017, The Journal of pathology.

[6]  E. Rofstad,et al.  Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts , 2017, Acta oncologica.

[7]  K. Wong,et al.  Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20) , 2017, Current Oncology Reports.

[8]  F. Sotgia,et al.  Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. , 2017, Seminars in oncology.

[9]  M. Mego,et al.  Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients. , 2017, Anticancer research.

[10]  M. Clemons,et al.  Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Ichikawa,et al.  Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancer. , 2017, Immunotherapy.

[12]  Joel s. Brown,et al.  Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis , 2017, Molecular Cancer Research.

[13]  Yan Guo,et al.  The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies , 2017, International journal of genomics.

[14]  Alberto Mantovani,et al.  Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.

[15]  Massimo Cristofanilli,et al.  Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application , 2016, Oncotarget.

[16]  N. Samadi,et al.  Tumor microenvironment-mediated chemoresistance in breast cancer. , 2016, Breast.

[17]  Sun Wook Cho,et al.  Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment , 2016, Endocrinology and metabolism.

[18]  G. Che,et al.  Genetic alterations and epigenetic alterations of cancer-associated fibroblasts , 2016, Oncology letters.

[19]  J. Saez-Rodriguez,et al.  Looking beyond the cancer cell for effective drug combinations , 2016, Genome Medicine.

[20]  R. Varadhan,et al.  Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance. , 2016, The Journal of clinical investigation.

[21]  M. Fernández-Zapico,et al.  Epigenetic control of the tumor microenvironment. , 2016, Epigenomics.

[22]  E. Cukierman,et al.  Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions. , 2016, Current opinion in cell biology.

[23]  C. Cohen,et al.  Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer. , 2016, American journal of clinical pathology.

[24]  Joel s. Brown,et al.  Ecological paradigms to understand the dynamics of metastasis. , 2016, Cancer letters.

[25]  M. Seto,et al.  PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma. , 2016, Blood.

[26]  B. Fabry,et al.  ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion , 2016, Nature Communications.

[27]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[28]  Heikki Joensuu,et al.  Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription , 2016, Nature Communications.

[29]  C. Verbeke,et al.  Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells , 2016, Neoplasia.

[30]  R. Weichselbaum,et al.  Tumor-associated fibroblasts predominantly come from local and not circulating precursors , 2016, Proceedings of the National Academy of Sciences.

[31]  S. Hingorani,et al.  Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma. , 2016, Gastroenterology.

[32]  Renier J. Brentjens,et al.  Driving CAR T-cells forward , 2016, Nature Reviews Clinical Oncology.

[33]  J. Karp,et al.  A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer. , 2016, Biomaterials.

[34]  R. Kuick,et al.  Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer , 2016, Cell.

[35]  B. Hinz,et al.  The myofibroblast in wound healing and fibrosis: answered and unanswered questions , 2016, F1000Research.

[36]  G. Beatty,et al.  IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma. , 2016, Cancer discovery.

[37]  R. Khokha,et al.  Tumor suppression by stromal TIMPs , 2016, Molecular & cellular oncology.

[38]  T. Shimo,et al.  The Role of Sonic Hedgehog Signaling in Osteoclastogenesis and Jaw Bone Destruction , 2016, PloS one.

[39]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[40]  R. Faccio,et al.  Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development. , 2016, Cell reports.

[41]  P. Xu,et al.  Autophagy induction contributes to the resistance to methotrexate treatment in rheumatoid arthritis fibroblast-like synovial cells through high mobility group box chromosomal protein 1 , 2015, Arthritis Research & Therapy.

[42]  V. Sanz-Moreno,et al.  Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts , 2015, Nature Communications.

[43]  Erik Sahai,et al.  Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization , 2015, Cell reports.

[44]  S. Yano,et al.  Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab , 2015, Nature Communications.

[45]  Takaya Nagasaki,et al.  Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth , 2015, Cancers.

[46]  R. Datar,et al.  Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. , 2015, Cancer research.

[47]  Thomas M. Schmitt,et al.  T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma. , 2015, Cancer cell.

[48]  H. Riechelmann,et al.  Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells , 2015, Oncotarget.

[49]  E. Terpos,et al.  Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma. , 2015, BoneKEy reports.

[50]  Yuquan Wei,et al.  A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts , 2015, Scientific Reports.

[51]  A. Ribas.  Adaptive Immune Resistance: How Cancer Protects from Immune Attack. , 2015, Cancer Discovery.

[52]  V. Coccè,et al.  Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study , 2015, Stem Cell Research & Therapy.

[53]  Yan Sun,et al.  ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway. , 2015, Cancer research.

[54]  Dong Eun Kim,et al.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation , 2015, Nature Cell Biology.

[55]  Mohamed Hassan,et al.  Stromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic Target , 2015, Front. Oncol..

[56]  Karin Oien,et al.  Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy , 2015, EMBO molecular medicine.

[57]  B. Campbell,et al.  Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases. , 2015, Cancer research.

[58]  Lei Mu,et al.  Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer , 2015, PloS one.

[59]  F. Sotgia,et al.  Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells , 2015, Oncotarget.

[60]  Erik Sahai,et al.  Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling , 2015, Cancer cell.

[61]  Brian Ruffell,et al.  Macrophages and therapeutic resistance in cancer. , 2015, Cancer cell.

[62]  Jace W. Jones,et al.  Human bone marrow niche chemoprotection mediated by cytochrome p450 enzymes , 2015, Oncotarget.

[63]  N. Shore.  Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective. , 2015, Urology.

[64]  A. Griffioen,et al.  The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy , 2015, Pharmacological Reviews.

[65]  Song Liu,et al.  Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer , 2015, Cancer Microenvironment.

[66]  K. Pienta,et al.  Ecology meets cancer biology: The cancer swamp promotes the lethal cancer phenotype , 2015, Oncotarget.

[67]  E. Furth,et al.  Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma , 2015, Cancer Immunology Research.

[68]  P. Herzig,et al.  Induced PD-L1 Expression Mediates Acquired Resistance to Agonistic Anti-CD40 Treatment , 2015, Cancer Immunology Research.

[69]  Jun Luo,et al.  Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study , 2015, Science Translational Medicine.

[70]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[71]  P. Nelson,et al.  DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance , 2014, Oncotarget.

[72]  I. Holen,et al.  Prostate Cancer Cells Preferentially Home to Osteoblast‐rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[73]  Z. Werb,et al.  Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.

[74]  H. Ohmatsu,et al.  Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation , 2014, Clinical Cancer Research.

[75]  Tsuyoshi Saito,et al.  Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity , 2014, Laboratory Investigation.

[76]  S. Hayward,et al.  Stromal androgen receptor in prostate development and cancer. , 2014, The American journal of pathology.

[77]  G. Wahl,et al.  Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy , 2014, Cell.

[78]  S. Rosati,et al.  CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model , 2014, Clinical & Experimental Metastasis.

[79]  Y. Okada,et al.  Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state , 2014, Nature Cell Biology.

[80]  Y. Shiozawa,et al.  Annexin 2–CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow , 2014, Molecular Cancer Research.

[81]  L. Chin,et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.

[82]  Stephen A. Sastra,et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. , 2014, Cancer cell.

[83]  S. Tartare-Deckert,et al.  LIF mediates proinvasive activation of stromal fibroblasts in cancer. , 2014, Cell reports.

[84]  Rohit Bhargava,et al.  Integration of Molecular Profiling and Chemical Imaging to Elucidate Fibroblast-Microenvironment Impact on Cancer Cell Phenotype and Endocrine Resistance in Breast Cancer , 2014, PloS one.

[85]  Marc L. Mendillo,et al.  The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy , 2014, Cell.

[86]  Hui Zhang,et al.  Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells. , 2014, Cancer letters.

[87]  Janna Paulsson,et al.  Prognostic relevance of cancer-associated fibroblasts in human cancer. , 2014, Seminars in cancer biology.

[88]  Guanqing Ou,et al.  Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression , 2014, Nature Medicine.

[89]  S. Gordon,et al.  The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.

[90]  H. Nakagama,et al.  FGF Receptors: Cancer Biology and Therapeutics , 2014, Medicinal research reviews.

[91]  L. Blavier,et al.  Bone Marrow–Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells , 2014, Molecular Cancer Therapeutics.

[92]  J. Brown,et al.  Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy. , 2014, The British journal of radiology.

[93]  Payam Shahi,et al.  FGFR1-WNT-TGF-β signaling in prostate cancer mouse models recapitulates human reactive stroma. , 2014, Cancer research.

[94]  R. Rabadán,et al.  Leukemogenesis Induced by an Activating β-catenin mutation in Osteoblasts , 2014, Nature.

[95]  Feng Yu,et al.  A Vaccine That Co-Targets Tumor Cells and Cancer Associated Fibroblasts Results in Enhanced Antitumor Activity by Inducing Antigen Spreading , 2013, PloS one.

[96]  Derek S. Chan,et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.

[97]  G. Kibria,et al.  Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system , 2013, Archives of Pharmacal Research.

[98]  E. Puré,et al.  Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity , 2013, Cancer Immunology Research.

[99]  P. Bragado,et al.  TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signalling , 2013, Nature Cell Biology.

[100]  Richard C. McEachin,et al.  Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer , 2013, PloS one.

[101]  J. Isaacs,et al.  Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment. , 2013, Endocrine-related cancer.

[102]  H. Schreiber,et al.  Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.

[103]  Richard J. Jones,et al.  Regulation of human hematopoietic stem cell self-renewal by the microenvironment’s control of retinoic acid signaling , 2013, Proceedings of the National Academy of Sciences.

[104]  M. Egeblad,et al.  System-Wide Analysis Reveals a Complex Network of Tumor-Fibroblast Interactions Involved in Tumorigenicity , 2013, PLoS genetics.

[105]  Y Quijano,et al.  Stromal disrupting effects of nab-paclitaxel in pancreatic cancer , 2013, British Journal of Cancer.

[106]  D. Strunk,et al.  Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment. , 2013, Blood.

[107]  Y. Ni,et al.  Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis , 2013, Journal of Cancer Research and Clinical Oncology.

[108]  T. Wang,et al.  Bone marrow cells as precursors of the tumor stroma. , 2013, Experimental cell research.

[109]  Olivia Yueh-Wen Liao,et al.  Stromal Responses among Common Carcinomas Correlated with Clinicopathologic Features , 2013, Clinical Cancer Research.

[110]  G. Semenza,et al.  Collagen prolyl hydroxylases are essential for breast cancer metastasis. , 2013, Cancer research.

[111]  F. Sánchez-Guijo,et al.  Uptake and delivery of antigens by mesenchymal stromal cells. , 2013, Cytotherapy.

[112]  Robert P. Jenkins,et al.  Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts , 2013, Nature Cell Biology.

[113]  E. Raymond,et al.  Stromal expression of SPARC in pancreatic adenocarcinoma , 2013, Cancer and Metastasis Reviews.

[114]  Ling Wu,et al.  Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: Perspectives from stem cell biology and molecular medicine , 2013, Journal of cellular physiology.

[115]  K. Pienta,et al.  GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation , 2013, PloS one.

[116]  L. Moroni,et al.  Human mesenchymal stem cells: A bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues , 2013, Journal of cellular physiology.

[117]  N. Ikeda,et al.  Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype. , 2013, Chest.

[118]  J. Erler,et al.  LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. , 2013, Cancer research.

[119]  R. Bellamkonda,et al.  Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism. , 2013, Cancer research.

[120]  Y. Hida,et al.  Tumour endothelial cells acquire drug resistance in a tumour microenvironment. , 2013, Journal of biochemistry.

[121]  C. Parker,et al.  Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases. , 2013, Clinical genitourinary cancer.

[122]  P. Clézardin.  Mechanisms of action of bisphosphonates in oncology: a scientific concept evolving from antiresorptive to anticancer activities. , 2013, BoneKEy reports.

[123]  Cyrus Chargari,et al.  Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. , 2013, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[124]  Hao Liu,et al.  Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[125]  Paolo P. Provenzano,et al.  Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer , 2013, British Journal of Cancer.

[126]  K. Pienta,et al.  Circulating fibroblast‐like cells in men with metastatic prostate cancer , 2013, The Prostate.

[127]  J. Chirgwin,et al.  Halofuginone inhibits the establishment and progression of melanoma bone metastases. , 2012, Cancer research.

[128]  Mats Lambe,et al.  CD99 is a novel prognostic stromal marker in non‐small cell lung cancer , 2012, International journal of cancer.

[129]  P. Jung,et al.  Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.

[130]  A. Scott,et al.  Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies , 2012, Clinical Cancer Research.

[131]  Judith Campisi,et al.  Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B , 2012, Nature Medicine.

[132]  E. D. de Vries,et al.  CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. , 2012, Neoplasia.

[133]  C. Kuperwasser,et al.  Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met , 2012, Breast Cancer Research.

[134]  B. Coulomb,et al.  The myofibroblast, multiple origins for major roles in normal and pathological tissue repair , 2012, Fibrogenesis & tissue repair.

[135]  T. Golub,et al.  Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretion , 2012, Nature.

[136]  Y. Miao,et al.  High expression of Galectin‐1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer , 2012, International journal of cancer.

[137]  D. Piwnica-Worms,et al.  Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. , 2012, Cancer research.

[138]  L. Busund,et al.  Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced , 2012, Radiation oncology.

[139]  M. Baron,et al.  Loss of PPARγ expression by fibroblasts enhances dermal wound closure , 2012, Fibrogenesis & tissue repair.

[140]  K. Pienta,et al.  Disrupting the Networks of Cancer , 2012, Clinical Cancer Research.

[141]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[142]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[143]  L. Coussens,et al.  Accessories to the crime: functions of cells recruited to the tumor microenvironment. , 2012, Cancer cell.

[144]  Pierre Validire,et al.  Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. , 2012, The Journal of clinical investigation.

[145]  Christopher S. Chen,et al.  Matrix rigidity regulates a switch between TGF-β1–induced apoptosis and epithelial–mesenchymal transition , 2012, Molecular biology of the cell.

[146]  R. Baskar,et al.  Cancer and Radiation Therapy: Current Advances and Future Directions , 2012, International journal of medical sciences.

[147]  J. Schneider,et al.  Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. , 2012, Cancer research.

[148]  D. Newgreen,et al.  Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment , 2012, Cancer Microenvironment.

[149]  Rui Liu,et al.  Fibroblast activation protein , 2012, Cancer biology & therapy.

[150]  W. El-Deiry,et al.  CTGF-mediated autophagy-senescence transition in tumor stroma promotes anabolic tumor growth and metastasis , 2012, Cell cycle.

[151]  J. Isaacs,et al.  Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer , 2012, Oncotarget.

[152]  T. Clackson,et al.  Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models , 2012, Molecular Cancer Therapeutics.

[153]  A. Maitra,et al.  Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[154]  Hans Clevers,et al.  Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression. , 2011, Gastroenterology.

[155]  Thomas Filleron,et al.  Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. , 2011, Cancer research.

[156]  K. Pienta,et al.  Homing of Cancer Cells to the Bone , 2011, Cancer Microenvironment.

[157]  Y. Taniyama,et al.  Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model. , 2011, International journal of molecular medicine.

[158]  I. Fidler,et al.  The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs , 2011, International journal of cancer.

[159]  T. Guise,et al.  Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.

[160]  M. Delorenzi,et al.  Identification of Prognostic Molecular Features in the Reactive Stroma of Human Breast and Prostate Cancer , 2011, PloS one.

[161]  A. Masamune,et al.  Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling. , 2011, Cancer research.

[162]  David C. Smith,et al.  Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients , 2011, Clinical Cancer Research.

[163]  Nikolina Radulovich,et al.  Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer , 2011, Proceedings of the National Academy of Sciences.

[164]  Yao‐Hua Song,et al.  Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony‐forming potential , 2011, Biology of the cell.

[165]  K. Pienta,et al.  Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. , 2011, The Journal of clinical investigation.

[166]  H. Duffy,et al.  Fibroblasts and Myofibroblasts: What Are We Talking About? , 2011, Journal of cardiovascular pharmacology.

[167]  Drew A. Torigian,et al.  CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans , 2011, Science.

[168]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[169]  D. Roberts,et al.  Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer. , 2011, Cancer research.

[170]  M. D’Incalci,et al.  E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models. , 2011, Cancer research.

[171]  H. Tomita,et al.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.

[172]  Jerome Ritz,et al.  The elusive nature and function of mesenchymal stem cells , 2011, Nature Reviews Molecular Cell Biology.

[173]  L. Matrisian,et al.  TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. , 2011, Cancer research.

[174]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α , 2010, Science.

[175]  Bo Mu,et al.  Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model , 2010, Cancer science.

[176]  Luke A. Gilbert,et al.  DNA Damage-Mediated Induction of a Chemoresistant Niche , 2010, Cell.

[177]  Nhi N. Y. Vo,et al.  GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling. , 2010, Cancer research.

[178]  R. Jain,et al.  Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation. , 2010, Cancer research.

[179]  Sudha Agarwal,et al.  Mechanical Signals Activate Vascular Endothelial Growth Factor Receptor-2 To Upregulate Endothelial Cell Proliferation during Inflammation , 2010, The Journal of Immunology.

[180]  Ronald G. Tompkins,et al.  Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing , 2010, Cell transplantation.

[181]  Donald E Ingber,et al.  Mechanical control of tissue and organ development , 2010, Development.

[182]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[183]  K. Edlund,et al.  Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. , 2010, Cancer research.

[184]  J. Kramer,et al.  Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology? , 2010, Transfusion Medicine and Hemotherapy.

[185]  C. Tatu,et al.  Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences , 2010, Journal of cellular and molecular medicine.

[186]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[187]  K. Pienta,et al.  GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. , 2010, Neoplasia.

[188]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[189]  A. Friedl,et al.  Heterogeneity of Gene Expression in Stromal Fibroblasts of Human Breast Carcinomas and Normal Breast , 2009, Oncogene.

[190]  Richard O. Hynes,et al.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[191]  M. Andreeff,et al.  Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.

[192]  Min Liu,et al.  Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway. , 2009, Cancer letters.

[193]  N. Turner,et al.  Cardiac fibroblasts: at the heart of myocardial remodeling. , 2009, Pharmacology & therapeutics.

[194]  M. Korc,et al.  The role of fibroblast growth factors in tumor growth. , 2009, Current cancer drug targets.

[195]  M. Tammi,et al.  4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. , 2009, Experimental cell research.

[196]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[197]  P. Stattin,et al.  Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients , 2009, The Prostate.

[198]  F. Sotgia,et al.  An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. , 2009, The American journal of pathology.

[199]  A. LeBeau,et al.  Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin , 2009, Molecular Cancer Therapeutics.

[200]  O. Halevy,et al.  Inhibition of Transforming Growth Factor &bgr; Signaling by Halofuginone as a Modality for Pancreas Fibrosis Prevention , 2009, Pancreas.

[201]  Bethan Psaila,et al.  The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.

[202]  S. Bao,et al.  The multifaceted role of periostin in tumorigenesis , 2009, Cellular and Molecular Life Sciences.

[203]  W. Gerald,et al.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. , 2009, The Journal of clinical investigation.

[204]  A. Ostman,et al.  Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. , 2009, Current opinion in genetics & development.

[205]  D. Piwnica-Worms,et al.  Senescent stromal-derived osteopontin promotes preneoplastic cell growth. , 2009, Cancer research.

[206]  Glen Kristiansen,et al.  Analysis of DNA Methylation of Multiple Genes in Microdissected Cells From Formalin-fixed and Paraffin-embedded Tissues , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[207]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[208]  I. Kasman,et al.  PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. , 2009, Cancer cell.

[209]  Sandya Liyanarachchi,et al.  Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells. , 2008, Cancer research.

[210]  Robert Axelrod,et al.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. , 2008, Translational oncology.

[211]  V. Seshan,et al.  Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. , 2008, Cancer research.

[212]  S. Toda,et al.  Irradiated fibroblast‐induced bystander effects on invasive growth of squamous cell carcinoma under cancer–stromal cell interaction , 2008, Cancer science.

[213]  Y. Shyr,et al.  Transforming Growth Factor-β Signaling–Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion , 2008, Molecular Cancer Research.

[214]  A. Rosenberg,et al.  Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy , 2008, Cancer biology & therapy.

[215]  K. Heider,et al.  Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts , 2008, Clinical Cancer Research.

[216]  Mina J Bissell,et al.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. , 2008, Cancer research.

[217]  S. Hanks,et al.  The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling. , 2008, Molecular biology of the cell.

[218]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[219]  Zhengxin Wang,et al.  Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion , 2008, Journal of cellular and molecular medicine.

[220]  D. Hanahan,et al.  Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting , 2008, PLoS medicine.

[221]  R. Khokha,et al.  The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis , 2008, Critical reviews in clinical laboratory sciences.

[222]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[223]  R. Chambers,et al.  Regulation of matrix turnover: fibroblasts, forces, factors and fibrosis. , 2007, Biochemical Society transactions.

[224]  M. Haniffa,et al.  Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells1 , 2007, The Journal of Immunology.

[225]  Yamaguchi Masanori,et al.  Inhibitory effect of 4‐methylesculetin on hyaluronan synthesis slows the development of human pancreatic cancer in vitro and in nude mice , 2007, International journal of cancer.

[226]  Giulio Gabbiani,et al.  The myofibroblast: one function, multiple origins. , 2007, The American journal of pathology.

[227]  H. Heng,et al.  Dynamic stromal‐epithelial interactions during progression of MCF10DCIS.com xenografts , 2007, International journal of cancer.

[228]  H. Moses,et al.  Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. , 2007, The Journal of clinical investigation.

[229]  E. Kubista,et al.  Differential gene expression profile in breast cancer-derived stromal fibroblasts , 2007, Breast Cancer Research and Treatment.

[230]  J. Caetano-Lopes,et al.  Osteoblasts and bone formation. , 2007, Acta reumatologica portuguesa.

[231]  J. Gillespie,et al.  Identification of a unique epigenetic sub‐microenvironment in prostate cancer , 2007, The Journal of pathology.

[232]  W. Dalton,et al.  β1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells , 2007, British journal of haematology.

[233]  W. Dalton,et al.  Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. , 2006, Blood.

[234]  N. Cordes.  Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury. , 2006, Cancer letters.

[235]  M. Loeffler,et al.  Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.

[236]  P. Delmas,et al.  Bone quality--the material and structural basis of bone strength and fragility. , 2006, The New England journal of medicine.

[237]  G. Lavoie,et al.  The role of DNA hypomethylation in the control of stromelysin gene expression. , 2006, Biochemical and biophysical research communications.

[238]  R. Lutz,et al.  Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing. , 2006, Cancer research.

[239]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[240]  H. Geinitz,et al.  β1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury , 2006, Oncogene.

[241]  J. Gillespie,et al.  Gene promoter methylation in prostate tumor-associated stromal cells. , 2006, Journal of the National Cancer Institute.

[242]  Majid Ezzati,et al.  Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors , 2005, The Lancet.

[243]  O. Franco,et al.  Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. , 2005, Cancer research.

[244]  A. Hargens,et al.  A simple method for measuring interstitial fluid pressure in cancer tissues. , 2005, Microvascular research.

[245]  L. Castello,et al.  Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor , 2005, Journal of cellular physiology.

[246]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[247]  A. Agarwal,et al.  PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.

[248]  H. Wada,et al.  Matrix Metalloproteinase-2 Status in Stromal Fibroblasts, Not in Tumor Cells, Is a Significant Prognostic Factor in Non–Small-Cell Lung Cancer , 2004, Clinical Cancer Research.

[249]  M. Goggins,et al.  Gene Expression Profiling of Tumor–Stromal Interactions between Pancreatic Cancer Cells and Stromal Fibroblasts , 2004, Cancer Research.

[250]  W. Frankel,et al.  Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles , 2004, Oncogene.

[251]  A. Ostman,et al.  Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? , 2004, Lung cancer.

[252]  K. Ohuchida,et al.  Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. , 2004, Cancer research.

[253]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[254]  Ash A. Alizadeh,et al.  Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.

[255]  L. Kunz-Schughart,et al.  The fibroblast: Sentinel cell and local immune modulator in tumor tissue , 2004, International journal of cancer.

[256]  P. Scardino,et al.  Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[257]  E. Mackie,et al.  Osteoblasts: novel roles in orchestration of skeletal architecture. , 2003, The international journal of biochemistry & cell biology.

[258]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[259]  K. Pienta,et al.  Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo , 2003, Journal of cellular biochemistry.

[260]  Gideon A. Rodan,et al.  Control of osteoblast function and regulation of bone mass , 2003, Nature.

[261]  S. Larson,et al.  A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[262]  W. Dalton,et al.  Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells , 2003, Oncogene.

[263]  T. Guise,et al.  The vicious cycle of bone metastases. , 2002, Journal of musculoskeletal & neuronal interactions.

[264]  Satoshi Matsumoto,et al.  Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas , 2002, Nature Genetics.

[265]  G. Ayala,et al.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[266]  J. Drevs,et al.  Contents of Next Issues · Themenvorschau , 2002, Oncology Research and Treatment.

[267]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[268]  P. Brodt,et al.  Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF‐I and EGF , 2002, International journal of cancer.

[269]  S. Hayward,et al.  Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.

[270]  S. Lemeshow,et al.  Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. , 2001, Human molecular genetics.

[271]  JS Damiano,et al.  Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation , 2001, Leukemia.

[272]  K. Pfizenmaier,et al.  Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas , 2001, International journal of cancer.

[273]  J. Lord,et al.  Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. , 2001, Trends in immunology.

[274]  S. Khosla,et al.  The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated* *This work was supported by Grant AG-04875 from the National Institute on Aging. , 2000, Endocrinology.

[275]  W. Dalton,et al.  Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR) , 2000, Oncogene.

[276]  G. Karsenty,et al.  The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.

[277]  R. Maini,et al.  Mesenchymal precursor cells in the blood of normal individuals , 2000, Arthritis Research & Therapy.

[278]  P. Conget,et al.  Mesenchymal progenitor cells in human umbilical cord blood , 2000, British journal of haematology.

[279]  P. Watkins,et al.  The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[280]  M. Barcellos-Hoff,et al.  Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.

[281]  G. Cunha,et al.  Mesenchymal reprogramming of adult human epithelial differentiation. , 1999, Differentiation; research in biological diversity.

[282]  R. Cancedda,et al.  Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. , 1999, Experimental hematology.

[283]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[284]  W. Muller,et al.  Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. , 1999, Journal of cell science.

[285]  N. Fusenig,et al.  Defects of basement membrane and hemidesmosome structure correlate with malignant phenotype and stromal interactions in HaCaT-Ras xenografts. , 1999, Differentiation; research in biological diversity.

[286]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[287]  R. Xavier,et al.  Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.

[288]  A. Nagler,et al.  Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis. , 1997, Journal of hepatology.

[289]  Terry J. Smith,et al.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. , 1997, The American journal of pathology.

[290]  A. Caplan,et al.  Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine , 1995, Muscle & nerve.

[291]  Helen Muir,et al.  The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[292]  J. Urban,et al.  The chondrocyte: a cell under pressure. , 1994, British journal of rheumatology.

[293]  Zhongyun Dong,et al.  Modulation of tumor cell response to chemotherapy by the organ environment , 1994, Cancer and Metastasis Reviews.

[294]  A. Scott,et al.  Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[295]  H. Schreiber,et al.  Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells , 1992, The Journal of experimental medicine.

[296]  Y. Kawarada,et al.  Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[297]  R K Jain,et al.  Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.

[298]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[299]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[300]  G. Cunha,et al.  Stromal-epithelial interactions and heterogeneity of proliferative activity within the prostate. , 1986, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[301]  P. Cooke,et al.  Stromal-epithelial interactions in adult organs. , 1985, Cell differentiation.

[302]  A. Piersma,et al.  Characterization of fibroblastic stromal cells from murine bone marrow. , 1985, Experimental hematology.

[303]  J. Little,et al.  Adaptation of human diploid fibroblasts in vitro to serum from different sources. , 1983, Journal of cell science.

[304]  E. Schneider,et al.  Tissue-specific differences in cultured human diploid fibroblasts. , 1977, Experimental cell research.

[305]  N. Kulagina,et al.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.

[306]  G. Cunha.  The role of androgens in the epithelio‐mesenchymal interactions involved in prostatic morphogenesis in embryonic mice , 1973, The Anatomical record.

[307]  G. Cunha.  Tissue interactions between epithelium and mesenchyme of urogenital and integumental origin , 1972, The Anatomical record.

[308]  G. Cunha.  Epithelio‐mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation , 1972, The Anatomical record.

[309]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[310]  A. Friedenstein,et al.  Osteogenesis in transplants of bone marrow cells. , 1966, Journal of embryology and experimental morphology.

[311]  C E LUMSDEN,et al.  The significance of the tissue pressure of normal testicular and of neoplastic (Brown-Pearce carcinoma) tissue in the rabbit. , 1950, The Journal of pathology and bacteriology.

[312]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[313]  Junjeong Choi,et al.  Adipocyte biology in breast cancer: From silent bystander to active facilitator. , 2018, Progress in lipid research.

[314]  Hiroshi I. Suzuki,et al.  TBX4 is involved in the super-enhancer-driven transcriptional programs underlying features specific to lung fibroblasts. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[315]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[316]  F. Jakob,et al.  Breast carcinoma cells modulate the chemoattractive activity of human bone marrow‐derived mesenchymal stromal cells by interfering with CXCL12 , 2015, International journal of cancer.

[317]  Alexandra Naba,et al.  Overview of the matrisome--an inventory of extracellular matrix constituents and functions. , 2012, Cold Spring Harbor perspectives in biology.

[318]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[319]  E. Mackie,et al.  Endochondral ossification: how cartilage is converted into bone in the developing skeleton. , 2008, The international journal of biochemistry & cell biology.

[320]  P. Weinreb,et al.  Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis , 2008 .

[321]  K. Pienta,et al.  Expression and activation of αvβ3 integrins by SDF‐1/CXC12 increases the aggressiveness of prostate cancer cells , 2007 .

[322]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[323]  F. Marini,et al.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. , 2005, Cytotherapy.

[324]  W. Dalton,et al.  Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies , 2004, Cancer and Metastasis Reviews.

[325]  M. Bloomston,et al.  TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. , 2002, The Journal of surgical research.

[326]  K. Claffey,et al.  Fibroblast Growth Factor 2 Activation of Stromal Cell Vascular Endothelial Growth Factor Expression and Angiogenesis , 2001, Laboratory Investigation.

[327]  G. Adler,et al.  Platelet-Derived Growth Factors Stimulate Proliferation and Extracellular Matrix Synthesis of Pancreatic Stellate Cells: Implications in Pathogenesis of Pancreas Fibrosis , 2000, Laboratory Investigation.

[328]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[329]  B. Shenker,et al.  Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. , 1994, Developmental biology.

[330]  Alfonso Martinez Arias,et al.  Molecular biology of the cell (2nd edn): edited by B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts and J.D, Watson, Garland, 1989 $46.95 (v + 1187 pages) ISBN 0 8240 3695 6 , 1989 .

[331]  J. Bingham.  Letter: Lower oesophageal sphincter. , 1974, Lancet.

[332]  T. Tlsty,et al.  Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium , 2022 .